HRA® offers compensation of $250 to Advanced Practice Providers for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.

Please note: this is a non-CME, independently produced program. All content is developed by the Urology Times® team.

OVERVIEW

The Expert APProach Summit is a Urology Times® program for urology advanced practice providers (nurse practitioners and physician assistants). The in-person summit combines a leadership-focused opening session, networking with peers, and small-group clinical forum discussions, providing a platform for peer-to-peer collaboration aimed at elevating and improving patient care.

AGENDA (all times CT; times subject to change)

2:00 - 2:45 PM | Registration and Networking

2:45 - 4:15 PM | Opening Session: The Expert APProach LIVE! with Joy Maulik, CRNP

All attendees. An interactive, non-clinical discussion on healthcare leadership for urology APPs. Topics include:

• Leadership development in urology practice
• Building relationships with urologists
• Addressing APP burnout
• Becoming a key opinion leader (KOL)

4:15 - 5:45 PM | Networking Break and Refreshments

5:45 - 6:45 PM | Clinical Forum Breakout Discussions

Attendees join one of the following discussion topics, selected during registration:

Advancing Care in Non-Muscle Invasive Bladder Cancer for the Advanced Practice Provider

Moderator: Samantha Steinke, MSN, APRN, FNP-C | Northwestern Medicine

• Explore multidisciplinary management strategies for non-muscle invasive bladder cancer and the evolving roles of urology and medical oncology providers.
• Evaluate current and emerging clinical data and understand how these data may impact future treatment strategies.
• Discuss real-world best practices and current challenges in managing patients with non-muscle invasive bladder cancer from an advanced practice provider perspective.

From Trial to Treatment: Applying the Latest Evidence in mCSPC Management

Moderator: Brenda Martone, MSN, ANP-BC, AOCNP | Northwestern Medicine

• Describe current treatment paradigms for metastatic castration-sensitive prostate cancer (mCSPC)
• Assess key clinical factors that influence the selection of systemic therapies in patients with newly diagnosed mCSPC
• Discuss how emerging clinical evidence and recent therapeutic advances are shaping individualized treatment strategies in mCSPC

6:45 - 7:15 PM | Recap Session

7:15 - 7:20 PM | Closing Remarks